SEC Form 4 · accession 0001468316-26-000023
FENNEC PHARMACEUTICALS INC. · FENC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rosty Raykov
Other
Period of report
Aug 31, 2026
Accepted (ET)
Sep 1, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001211583
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common sharesF1 | Aug 31, 2026 | A | 2,778 | $0.00 | A | 134,411 | D | |
| Common sharesF2 | Sep 1, 2026 | S | 10,000 | $12.11 | D | 124,411 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares released from restriction from shares awarded 5/16/2024.
- F2Represents shares sold pursuant to a 10b5-1 plan dated September 19, 2025.